Pabau Engage inbox

Pabau Engage is here: every patient conversation in one inbox.

Learn more
Book a demo Book a demo
☰
CPT Code

CPT code 90688 – Quadrivalent influenza vaccine billing


Code Definition

90688 is the CPT code for influenza virus vaccine, quadrivalent (IIV4), split virus, when administered to individuals 3 years of age and older, for intramuscular use.

CPT code 90688 is the quadrivalent inactivated influenza vaccine (IIV4) administered intramuscularly, covering standard-dose four-strain formulations for patients of all ages. Where practices most often stumble is not knowing the code itself but picking the wrong neighbor: 90686 describes a preservative-free IIV4 formulation, and high-dose and adjuvanted variants carry entirely separate codes. Getting that distinction wrong triggers a denial before the claim ever reaches a human reviewer. Medicare Part B covers CPT code 90688 with no deductible or coinsurance, but some Medicare Administrative Contractors (MACs) require Q-codes instead, making MAC-jurisdiction verification one of the first billing steps.

Section
90281-99199 Medicine
Billable
No
Code also known as
flu shot vaccine code, IIV4 billing code, quadrivalent flu vaccine CPT, four-strain influenza vaccine code
Save time. Improve accuracy. Get paid faster.
Automate coding with Pabau

Let Pabau's smart automation suggest the right codes, reduce claim denials, and keep your practice compliant—effortlessly.

  • AI-powered code suggestions
  • Real-time compliance checks
  • Faster claims, fewer denials
Why practices choose Pabau
Save hours every week

Automate repetitive tasks and focus on what matters most—your patients.

Improve accuracy

Reduce coding errors and ensure compliance with the latest regulations.

Get paid faster

Clean claims, fewer denials, and faster reimbursements.

Grow with confidence

Powerful insights and reporting to help your practice thrive.

HIPAA compliant SOC 2 certified GDPR-compliant Trusted by 4,000+ clinics worldwide

Key Takeaways

Key Takeaways

CPT code 90688 covers standard-dose quadrivalent inactivated influenza vaccine (IIV4), intramuscular route, any age; it does not cover high-dose, adjuvanted, recombinant, or trivalent formulations

Always bill a separate administration code alongside 90688: 90471 for the first vaccine in an encounter, 90472 for each additional

Some MACs require HCPCS Q-codes (Q2036 through Q2040) instead of CPT code 90688 for Medicare Part B claims; verify your MAC policy before submitting

Pabau’s claims management software flags vaccine code mismatches and routes 90688 claims with the correct ICD-10 pairings before submission

CPT code 90688: Official descriptor and code definition

CPT code 90688, as maintained by the American Medical Association, describes the quadrivalent inactivated influenza vaccine administered intramuscularly. The official descriptor reads: “Influenza virus vaccine, quadrivalent (IIV4), split virus, when administered to individuals 3 years of age and older, for intramuscular use.” This covers the standard-dose four-strain inactivated preparation, whether preservative-containing or preservative-free, as long as the formulation meets the age and route criteria.

Three attributes define the code boundary: Formulation type (quadrivalent inactivated, split-virus), route (intramuscular only), and age threshold (3 years and older). Anything outside those three parameters requires a different code.

Attribute CPT 90688 Specification
Code 90688
Vaccine type Quadrivalent inactivated influenza vaccine (IIV4), split virus
Route Intramuscular (IM) only
Age range 3 years and older
Dose Standard dose (not high-dose or adjuvanted)
Preservative Either preservative-containing or preservative-free

What CPT code 90688 covers and what it does not

CPT code 90688 is narrower than it looks. The quadrivalent inactivated flu vaccine comes in several formulations, and each distinct variant has its own CPT code. Billing 90688 when the actual product administered was a high-dose or adjuvanted formulation is a miscoding error that payers audit. Cell-cultured Flucelvax Quadrivalent has its own code too, CPT 90674.

Included under 90688

  • Standard-dose quadrivalent IIV4 preparations (0.5 mL typical dose)
  • Preservative-containing and preservative-free versions of standard IIV4
  • Patients aged 3 years and older
  • Intramuscular administration (typically deltoid for adults, anterolateral thigh for children)

Not included under 90688

  • High-dose quadrivalent IIV4 (use 90687 for patients 65 years and older)
  • Adjuvanted quadrivalent IIV4 (use 90688’s adjuvanted sibling code)
  • Recombinant influenza vaccine (use 90682)
  • Intradermal formulations (use 90756 or the appropriate intradermal code)
  • Trivalent formulations (use 90685 or 90686 for IIV3)
  • Patients under 3 years (use 90685 for IIV4 in children 6 months through 35 months)
  • Live attenuated intranasal vaccine (use 90672)

How CPT code 90688 differs from 90686, 90685, and neighboring influenza vaccine codes

The influenza vaccine CPT code family spans a dozen codes, and they differ across four axes: Strains covered (trivalent vs. quadrivalent), formulation type (inactivated, recombinant, live attenuated), dose level (standard vs. high-dose), and age range. The table below covers the codes most frequently confused with 90688.

Code Descriptor summary Strains Dose / formulation Age group
90685 IIV4, split virus, IM Quadrivalent Standard dose, inactivated 6 months through 35 months
90686 IIV4, split virus, PF, IM Quadrivalent Standard dose, preservative-free 3 years and older
90687 IIV4, high dose, IM Quadrivalent High dose (60 mcg per strain) 65 years and older
90688 IIV4, split virus, IM (THIS CODE) Quadrivalent Standard dose, pres. or pres.-free 3 years and older
90682 Recombinant influenza vaccine, IM Quadrivalent Recombinant (egg-free) 18 years and older
90756 IIV4, intradermal, PF Quadrivalent Standard dose, intradermal route 18 through 64 years

Key distinction between 90688 and 90686: Both cover standard-dose quadrivalent IIV4 for patients 3 years and older, administered intramuscularly. The sole difference is that 90686 is specifically preservative-free (PF). If the product you administered contains a preservative, 90688 is the correct code. If it is explicitly preservative-free and you want to reflect that in the claim, use 90686. Payers generally accept either for the same clinical event, but accuracy matters for audit purposes.

Which administration code to bill alongside CPT code 90688

CPT code 90688 is a product code only. It describes the vaccine itself, not the act of injecting it. Every claim for 90688 must include a separate administration code, or payers will deny the claim as incomplete.

Scenario Product code Administration code
Flu vaccine only (first vaccine in encounter) 90688 90471
Flu vaccine plus one additional vaccine in same encounter 90688 + other product code 90471 + 90472
Counseling provided with vaccine administration 90688 90471 (counseling add-on may apply)

Use 90472 for each additional vaccine beyond the first in the same encounter. If the patient receives the flu shot and a pneumococcal vaccine on the same day, the claim carries 90688 + 90671 (or 90670), plus 90471 for the first administration and 90472 for the second.

Under Medicare Part B, the administration code for influenza vaccines is a separate benefit line. CMS reimburses the administration at a distinct rate, so both the product code and the administration code should appear on the same claim form.

ICD-10 diagnosis codes to pair with CPT code 90688

Every CPT 90688 claim needs a supporting ICD-10-CM diagnosis code. The CMS ICD-10 coding guidance designates Z23 as the primary diagnosis code for all vaccine encounter claims. High-risk condition codes may be added as secondary diagnoses but are not required for a clean claim.

ICD-10-CM code Description When to use
Z23 Encounter for immunization Primary code for all routine flu vaccine encounters
J10.1 Influenza due to other identified influenza virus with other respiratory manifestations Do not use on a preventive vaccination claim; this is for active influenza diagnosis
Z87.891 Personal history of other specified conditions Secondary code when documenting high-risk history relevant to vaccine decision

Z23 alone is sufficient for the overwhelming majority of 90688 claims. Adding high-risk secondary codes (diabetes, chronic lung disease, immunosuppression) is clinically appropriate and can support medical necessity documentation for certain payers, but their absence does not cause denial on its own.

Pro Tip

Run a claim scrub that checks Z23 is in position 1 on every 90688 encounter before submission. Claims with an influenza diagnosis code in the primary position rather than Z23 can trigger payer queries, since those codes signal active disease treatment rather than preventive immunization.

Medicare Part B billing rules for CPT code 90688

Medicare Part B covers the influenza vaccine as a preventive benefit with no deductible and no coinsurance for the patient. The provider must accept assignment on the flu vaccine claim; non-par providers cannot collect the Medicare limiting charge on this service. Pabau’s claims management software captures these assignment requirements at the payer level so the claim is configured correctly before submission, and electronic claims route through electronic claims via Claim.MD, Pabau’s US clearinghouse partner, reaching over 4,000 payers including all Medicare MACs.

Automate claims through Healthcode
Automate claims through Healthcode

Medicare covers one influenza vaccine per flu season. An exception exists for immunocompromised patients who may require a second dose under physician order, but this exception is narrowly applied and must be documented explicitly.

CPT code 90688 vs. HCPCS Q-codes: Which to use for Medicare claims

This is the most common Medicare-specific confusion for 90688. Some MACs require HCPCS Q-codes instead of CPT 90688 for influenza vaccine claims submitted under Medicare Part B. The Q-codes (Q2036 through Q2040) describe specific branded influenza vaccine products and are not interchangeable with the CPT code from a MAC-policy standpoint.

HCPCS Q-code Corresponds to When applicable
Q2036 Afluria Quadrivalent When MAC requires product-specific Q-code for Medicare Part B
Q2037 Flulaval Quadrivalent When MAC requires product-specific Q-code for Medicare Part B
Q2038 Fluzone Quadrivalent When MAC requires product-specific Q-code for Medicare Part B
Q2039 Other seasonal influenza virus vaccine Catch-all Q-code when specific brand does not have an assigned Q-code

The correct approach: Check your MAC’s local coverage determination (LCD) for influenza vaccines each fall before the vaccination season begins. MAC policies on this point can and do change with annual CMS quarterly code updates. If your MAC requires Q-codes, bill the Q-code that matches the actual product administered, not 90688. Billing 90688 when your MAC requires Q2037 is a systematic denial that will not resolve through appeal until the code is corrected.

Automate your vaccine billing workflow

Pabau flags vaccine code mismatches, pairs the correct ICD-10 diagnosis codes, and routes claims through Claim.MD to 4,000+ payers including all Medicare MACs, reducing manual review time on seasonal immunization claims.

Pabau claims management dashboard

Common claim denials for CPT code 90688 and how to fix them

Most 90688 denials fall into five categories, and each one has a clear corrective action. Structured denial management workflows that map denial codes to root causes let billing staff resolve these without escalating each one individually.

Denial reason Root cause Corrective action
Code not covered / invalid for payer MAC requires Q-code, not CPT 90688 Rebill with correct Q-code (Q2036 through Q2039) matching the product administered
Missing NDC or lot number Some payers require the vaccine NDC on the claim line Add the 11-digit NDC in the required loop/segment on the 837P; verify payer requirement before next submission
Duplicate claim / seasonal limit exceeded Second flu vaccine submitted for same patient in same season without exception documentation If medically necessary (immunocompromised), appeal with physician order and clinical notes; otherwise void the duplicate
Missing administration code 90688 submitted without 90471 or 90472 Rebill with the administration code on a separate line; check that the original claim did not bundle administration
Wrong code for formulation / age 90688 used for a patient under 3 years or for a high-dose formulation Void the original claim; rebill with 90685 (under 3 years) or 90687 (high-dose for 65+)

Documentation requirements for a clean 90688 claim

Documentation failures are the second most common reason 90688 claims face post-payment audit or recoupment. A clean claim for a vaccine encounter requires specific data elements in the clinical record, beyond what a standard office visit note would contain. Using structured superbill documentation that captures vaccine-specific fields at the point of care prevents retrospective reconstruction.

  • Vaccine name and manufacturer: Record the full proprietary name (e.g. Fluzone Quadrivalent) and manufacturer, not just “influenza vaccine”
  • NDC and lot number: The 11-digit National Drug Code and vaccine lot number; some payers require NDC on the claim line itself
  • Administration date: The actual date the vaccine was given, which must match the claim date of service
  • Administration site and route: Left or right deltoid (or anterolateral thigh for pediatric patients), intramuscular route
  • Administering provider: Name and NPI of the clinician or qualified staff member who administered the vaccine
  • Patient consent: Documentation that the patient (or guardian) received the Vaccine Information Statement (VIS) and consented to vaccination
  • VFC eligibility notation: If the patient is Vaccines for Children (VFC) program eligible, that notation must appear in the chart; the vaccine product code billed does not change, but the funding source documentation is required for program compliance
  • ICD-10 diagnosis: Z23 as primary; additional codes for high-risk conditions if documented

Payer-specific influenza vaccine billing considerations beyond Medicare

Medicare gets most of the attention for flu vaccine billing, but Medicaid, commercial payers, and CHIP each have distinct rules that affect CPT code 90688 claims. Understanding medical billing fundamentals across these payer types prevents systematic denials at the program level.

Medicaid and VFC program

Medicaid coverage of the influenza vaccine varies by state, but all state Medicaid programs are required to cover Advisory Committee on Immunization Practices (ACIP)-recommended vaccines for children through the Vaccines for Children (VFC) program. VFC-eligible children receive vaccine product at no cost through the program; the practice bills only the administration code (90471) for VFC encounters, not the vaccine product code. For Medicaid-enrolled adults, state plan benefits determine coverage. Verify your state’s adult vaccine benefit before billing 90688 for adult Medicaid patients.

Commercial payers

Most commercial plans cover influenza vaccines as preventive services with no member cost-sharing under ACA preventive benefit rules, provided the administering provider is in-network. Prior authorization is rarely required for CPT 90688, but confirm your payer contract. Some commercial payers bundle the administration fee into a “global vaccine fee” and pay a single bundled rate for 90688 and 90471 combined, so breaking out the two line items may trigger a low-pay edit. Reviewing the ERA explanation for first-time 90688 submissions with each commercial payer catches bundling patterns before they become a systematic underpayment issue. Pabau’s electronic remittance tools let billers track ERA patterns by payer and flag contracts where administration codes are being bundled.

CHIP plans follow Medicaid coverage mandates for children, so the VFC rules above generally apply. Confirm state-specific CHIP plan billing requirements, as CHIP is administered at the state level and billing rules can diverge from standard Medicaid. Good billing compliance requirements documentation for each payer contract reduces rework at adjudication.

Pro Tip

Create a payer-specific vaccine billing matrix at the start of each flu season: list each major payer, the code they accept (90688 or Q-code), whether NDC is required on the claim line, and whether they bundle administration. Update it after reviewing the first ERAs of the season. This one document prevents the majority of systematic 90688 denials.

Conclusion

CPT code 90688 is straightforward in concept but prone to systematic errors in execution: MAC Q-code requirements, missing administration codes, NDC documentation gaps, and formulation mix-ups between 90688 and its neighbors account for most denials. Getting these right consistently requires payer-specific rules embedded in the billing workflow before claims leave the practice.

Pabau’s claims management platform supports practices in configuring these rules at the payer level, so vaccine claims route with the correct codes, ICD-10 pairings, and NDC documentation automatically. To see how Pabau handles vaccine billing workflows, explore the revenue cycle management approach or contact the team directly.

Continue your research

Continue your research

Need to understand how claims move through a clearinghouse? Claim.MD clearinghouse guide explains how electronic claims reach Medicare MACs and commercial payers.

Looking for the full denial code reference? Denial codes in medical billing covers CARC and RARC denial reason codes that appear on vaccine claim ERAs.

Want to benchmark your vaccine claim submission process? Best medical billing software in the US reviews platforms with built-in vaccine code validation and clearinghouse integration.

Frequently Asked Questions

What does CPT code 90688 cover?

CPT code 90688 is the quadrivalent inactivated influenza vaccine (IIV4), split virus, administered intramuscularly to patients 3 years and older. It covers standard-dose formulations, whether preservative-containing or preservative-free, but does not cover high-dose, adjuvanted, recombinant, intradermal, or trivalent influenza vaccine products.

Is CPT code 90688 covered by Medicare Part B?

Yes, Medicare Part B covers CPT code 90688 as a preventive benefit with no deductible and no coinsurance for the patient. The provider must accept assignment on the claim. Medicare covers one influenza vaccine per season, with limited exceptions for immunocompromised patients who require a second dose.

What is the difference between CPT codes 90688 and 90686?

Both codes describe standard-dose quadrivalent IIV4 for patients 3 years and older administered intramuscularly. The only difference is that 90686 is specifically preservative-free (PF), while 90688 applies to both preservative-containing and preservative-free formulations. If the product administered contains a preservative, 90688 is the correct code.

Why is CPT code 90688 being denied by my MAC?

The most common reason is that your Medicare Administrative Contractor requires a HCPCS Q-code (Q2036 through Q2039) instead of CPT 90688 for Medicare Part B influenza vaccine claims. Check your MAC’s local coverage determination for influenza vaccines at the start of each flu season and rebill with the Q-code that matches the actual product administered.

What ICD-10 code should be used with CPT code 90688?

Z23 (encounter for immunization) is the primary ICD-10-CM code for all routine influenza vaccine claims. Secondary codes for high-risk conditions such as diabetes or chronic lung disease may be added when documented but are not required for a clean claim.

What documentation is required to support a CPT code 90688 claim?

Required documentation includes: Vaccine proprietary name and manufacturer, NDC and lot number, date of administration, injection site and route (intramuscular), administering provider name and NPI, evidence that the Vaccine Information Statement was provided, and VFC eligibility notation if applicable. Some payers also require the NDC on the claim line itself.

×